339 results on '"Kenter G"'
Search Results
52. BLADDER, ANORECTAL AND SEXUAL FUNCTION AFTER NERVE-SPARING RADICAL HYSTERECTOMY FOR THE TREATMENT OF CERVICAL CANCER; A LONGITUDINAL PROSPECTIVE COHORT STUDY
53. The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study
54. Serial measurements of serum human epididymal protein 4 in patients at risk for ovarian cancer.
55. New biomarkers in epithelial ovarian cancer: needed or redundant?
56. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
57. Incidence of lymph node metastases in clinical early-stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study.
58. De beroepskeuze van in Leiden afgestudeerde artsen
59. HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
60. Zenuwsparende radicale hysterectomie bij cervixcarcinoom
61. Premaligne aandoeningen [35]
62. Aanbevelingen voor het beleid bij vrouwen met een erfelijk bepaalde hoge kans op gynaecologische kanker
63. De standaard 'Vaginaal bloedverlies' van het Nederlands Huisartsen Genootschap; reactie vanuit de gynaecologie
64. Long-term CIN3+risk in women with abnormal cytology; role of hrHPV testing
65. Effect of MRI on therapeutic decisions in invasive cervical carcinoma. Direct comparison with the pelvic examination as a preperative test
66. Cervixcarcinoom in een vroeg stadium operatief behandeld in het Leids Universitair Medisch Centrum, 1984-1996: ook infiltratiediepte, aantal en bilateraliteit van lymfeklierstations met metastasen prognostisch voor recidiefvorming
67. Goed hulpverlenerschap aan de grens van de wilsbekwaamheid
68. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma
69. 237 - Rational molecular assessment and innovative drug selection (RAIDs): Pharmacological profiling of 20 cervical cancer cell lines
70. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis
71. The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study.
72. Seksuele klachten en ervaringen met seksueel en fysiek geweld bij gynaecologische patiënten
73. 575 RAIDs: Rational Molecular Assessments and Innovative Drug Selection, an EU Funded Project
74. Diagnostics
75. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis
76. Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
77. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance
78. Microparticles and Exosomes in Gynecologic Neoplasias
79. Abstract CN01-03: Immunotherapy of established lesions caused by high-risk HPV
80. Expression of endoglin (CD105) in cervical cancer
81. An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model
82. Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report
83. Morbiditeit en resultaten van 100 radicale hysterectomieën verricht in een oncologisch centrum
84. The Gynaecologic Leiden Questionnaire: psychometric properties of a self‐report questionnaire of sexual function and vaginal changes for gynaecological cancer patients
85. Endothelium specific matrilysin (MMP-7) expression in human cancers
86. 100 INVITED Progress with cervix cancer vaccines. The end in sight?
87. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer
88. Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study
89. The absence ofCCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2
90. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study
91. Lessen uit gynaecologisch-pathologische besprekingen
92. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions
93. WOUND MORBIDITY AFTER VULVECTOMY AND INGUINOFEMORAL LYMPHADENECTOMY USING SEPARATE GROIN INCISIONS
94. LONG TERM SEQUELAE OF RADICAL HYSTERECTOMY: RESULTS OF A PROSPECTIVE STUDY WITH 2 YEARS FOLLOW-UP
95. PREVALENCE OF SINGLE AND MULTIPLE HPV TYPES IN CERVICAL CARCINOMAS IN JAKARTA, INDONESIA
96. THE EFFICACY OF SCREENING HIGH-RISK WOMEN FOR OVARIAN CANCER
97. Surgical treatment of low stage cervical carcinoma: Back to the old days?
98. A nerve-sparing radical hysterectomy: Guidelines and feasibility in Western patients
99. Human Papillomavirus Infection in Squamous Cell Carcinoma of the Vulva, in Various Synchronous Epithelial Changes and in Normal Vulvar Skin
100. CTL-mediated immunity against human papillomavirus type 16 E7-encoded epitopes presented by HLA-A2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.